Viscosupplementation market
Viscosupplementation Market, By Dosage (Single Injection, Three Injection, and Five Injection), By Arthritis Type (Osteoarthritis and Rheumatoid Arthritis), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
- Mar 2024
- CMI197
- 160 Pages
- Excel & Pdf
- Pharmaceutical
Summary
N/A
Table of Content
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Dosage
- Market Snapshot, By Arthritis Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- PEST Analysis
- Market Dynamics
- Global Viscosupplementation Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the Market
- Global Viscosupplementation Market, By Dosage, 2019 – 2031, (US$ Billion)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Single Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Three Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Five Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Overview
- Global Viscosupplementation Market, By Arthritis Type, 2019 – 2031, (US$ Billion)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Osteoarthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Rheumatoid Arthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Overview
- Global Viscosupplementation Market, By End User, 2019 – 2031, (US$ Billion)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Overview
- Global Viscosupplementation Market, By Region, 2019 – 2031, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019–2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (US$ Billion)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Anika Therapeutics Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Seikagaku Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ferring Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bioventus
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fidia Farmaceutici S.P.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ORTHOGENRX
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zimmer Biomet
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aptissen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Wellchem Pharmaceuticals Pte Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Juniper Biologics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ono Pharmaceutical Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Anika Therapeutics Inc
- Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
*Browse 25 market data tables and 25 figures on “Global Viscosupplementation Market” – Global forecast to 2031
Segmentation
Market Segmentation
- Dosage:
- Single Injection
- Three Injection
- Five Injection
- Arthritis Type:
- Osteoarthritis
- Rheumatoid Arthritis
- End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Frequently Asked Questions -
What are the major factors driving the viscosupplementation market growth?
Growing elderly population and risk of osteoarthritis and increased awareness and preference for non-surgical treatments are the major factors driving the growth of the viscosupplementation market.
What are the key factors hampering the growth of the viscosupplementation market?
High cost of viscosupplementation therapies and lack of reimbursement policies are the major factors hampering the growth of the viscosupplementation market.
Which is the leading dosage in the viscosupplementation market?
In terms of dosage, three injection is estimated to dominate the market revenue share in 2024.
Which are the major players operating in the viscosupplementation market?
Anika Therapeutics Inc., Seikagaku Corporation, Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., OrthogenRx, Teva Pharmaceutical Industries Ltd, Johnson & Johnson., F. Hoffmann-La Roche AG, Zimmer Biomet, Aptissen, Wellchem Pharmaceuticals Pte Ltd., Juniper Biologics, and Ono Pharmaceutical Co., Ltd are the major players.
Which region will lead the viscosupplementation market?
North America is expected to lead the viscosupplementation market.